NCS Multistage (NCSM) Projected to Post Quarterly Earnings on Wednesday

NCS Multistage (NASDAQ:NCSM) is expected to be issuing its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect the company to announce earnings of $1.17 per share and revenue of $46.10 million for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, October 30, 2025 at 8:30 AM ET.

NCS Multistage (NASDAQ:NCSM) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.46) by $1.80. The company had revenue of $36.45 million during the quarter, compared to analyst estimates of $27.60 million. NCS Multistage had a net margin of 7.18% and a return on equity of 12.50%.

NCS Multistage Stock Down 0.8%

NASDAQ:NCSM opened at $41.25 on Tuesday. The firm has a market cap of $104.78 million, a P/E ratio of 8.65 and a beta of 0.75. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.83 and a current ratio of 4.66. NCS Multistage has a fifty-two week low of $17.30 and a fifty-two week high of $53.69. The firm has a 50-day simple moving average of $43.71 and a two-hundred day simple moving average of $35.23.

Analysts Set New Price Targets

A number of analysts have weighed in on NCSM shares. Zacks Research lowered shares of NCS Multistage from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 3rd. Weiss Ratings restated a “hold (c-)” rating on shares of NCS Multistage in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

Insider Activity

In other news, Director Valerie A. Mitchell sold 1,969 shares of the firm’s stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $30.16, for a total transaction of $59,385.04. Following the sale, the director owned 23,551 shares of the company’s stock, valued at $710,298.16. This trade represents a 7.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 10.00% of the stock is currently owned by insiders.

Institutional Trading of NCS Multistage

A hedge fund recently raised its stake in NCS Multistage stock. NewEdge Advisors LLC grew its stake in shares of NCS Multistage Holdings, Inc. (NASDAQ:NCSM) by 3,774.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,175 shares of the company’s stock after acquiring an additional 7,964 shares during the quarter. NewEdge Advisors LLC owned about 0.32% of NCS Multistage worth $241,000 as of its most recent SEC filing. 70.91% of the stock is currently owned by institutional investors and hedge funds.

About NCS Multistage

NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves.